Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study

By sjmartinez • November 15, 2023

Rajdev L, Jackie Wang CC, Joshi H, Lensing S, Lee J, Ramos JC, Baiocchi R, Ratner L, Rubinstein PG, Ambinder R, Henry D, Streicher H, Little RF, Chiao E, Dittmer DP, Einstein MH, Cesarman E, Mitsuyasu R, Sparano JA; AIDS Malignancy Consortium. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study. Cancer. 2023 Nov 14. doi: 10.1002/cncr.35110. Epub ahead of print. PMID: 37962072.

Tags: CD4 count >100/µL, HIV cancer, immunotherapy, Infectious Diseases, nivolumab, Publications

Popular infection prevention myths related to single-use plastics

Lee PS, Abeles S, Mehrotra P, Mathew T, Jaggi P, Doshi S, Hsu V, Singh H. Popular infection prevention myths related to single-use plastics. Antimicrob[...]

Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial

Vyshenska D, Reed JC, Roychoudhury P, Zheng L, Olefsky M, Ritz J, McCarthy C, Saha PT, Hao L, Mills MG, Shea A, Nunley BE, Javan[...]

Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group

Osakwe CE, Schaefer R, Donaldson L, Abiodun AS, Chatani-Gada M, Chigome AK, Day S, Deaton C, Elemuwa UG, Ingold H, Joseph Davey D, Kersey K,[...]